Environmental and Health Notices




15 OCTOBER 2009 NEW ZEALAND GAZETTE, No. 152


Management (National Environmental Standards Relating to Certain Air Pollutants, Dioxins, and Other Toxics) Regulations 2004.

(2) Any areas within the Hawke’s Bay region which are not covered by the separate airsheds described in this notice form a single airshed for that region.

  1. Revocation—The Hawke’s Bay Regional Airshed Notice 2005, published in the New Zealand Gazette, 25 August 2005, No. 141, page 3430, is revoked.

Dated at Wellington this 3rd day of October 2009.

HON DR NICK SMITH, Minister for the Environment.

Schedule

Airshed Name Description
1. Napier SO 391819
2. Hastings SO 391819
3. Whirinaki SO 391819
4. Awatoto SO 391819

go8486


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Menitorix
Active Ingredients:

  • Haemophilus influenzae Type b PRP 5μg/dose
  • Neisseria meningitidis Group C 5μg/dose
  • Tetanus toxoid 17.5μg/dose
    Dosage Form: Powder for injection
    New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
    Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium

Product: Colgout
Active Ingredient: Colchicine 0.5mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Strides Arcolab Limited, Indlawadi Cross, Anekal Taluk, Bangalore, India

Dated this 8th day of October 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8491


Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product: Glivec
Active Ingredient: Imatinib mesilate 59.75mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland

Product: Glivec
Active Ingredient: Imatinib mesilate 119.5mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland

Dated this 8th day of October 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8492



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 152





✨ LLM interpretation of page content

Hawke’s Bay Regional Airshed Notice 2009 (continued from previous page)

Environment
3 October 2009
Resource Management Act 1991, Airsheds, Hawke’s Bay, Napier, Hastings, Whirinaki, Awatoto
  • HON DR NICK SMITH, Minister for the Environment

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
8 October 2009
Medicines Act 1981, New Medicines, Menitorix, Colgout, GlaxoSmithKline, Healthcare Logistics
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

🏥 Renewal of Provisional Consent to the Distribution of a Medicine

🏥 Health & Social Welfare
8 October 2009
Medicines Act 1981, Provisional Consent, Glivec, Novartis, Imatinib mesilate
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health